Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Moskowitz

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth yearH Takita, A Hollinshead, T Hart, et al.
The Journal of Rheumatology|July 1, 1995
Guidelines for testing slow acting drugs in arthritis--addendumM Lequesne, K Brandt, N Bellamy, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
Guidelines for testing slow acting drugs in osteoarthritisM Lequesne, K Brandt, N Bellamy, et al.
Plos One|March 22, 2016
Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint AnalysisRachel J Primrose, Toral Zaveri, Alyssa J Bakke, et al.
Foods (Basel, Switzerland)|October 31, 2020
Aroma, Quality, and Consumer Mindsets for Shelf-Stable Rice Thermally Processed by Reciprocal AgitationWilliam R Dixon, Blanca E Morales-Contreras, Manoch Kongchum, et al.
Vaccine|March 2, 2024
Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of careSarah G Yashar-Gershman, Alix T Rosenberg, Muskaan Sawhney, et al.
Journal of Surgical Oncology|January 1, 1991
Adjuvant, specific, active immunotherapy for resectable squamous cell lung carcinoma: a 5-year survival analysisH Takita, A C Hollinshead, R H Adler, et al.
Osteoarthritis and Cartilage|July 22, 2006
Commentary: osteoarthritis of the knee and glucosamineR D Altman, S Abramson, O Bruyere, et al.
Journal of Cardiovascular Pharmacology|June 8, 2001
Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteersM S Berlowitz, F Latif, S R Hankins, et al.
Annals of the Rheumatic Diseases|April 15, 2004
Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritisT Pincus, G Koch, H Lei, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cancer Immunology, Immunotherapy : CII|January 1, 1985
Adjuvant specific immunotherapy of resectable squamous cell lung carcinoma. Analysis at the eighth yearH Takita, A Hollinshead, T Hart, et al.
The Journal of Rheumatology|July 1, 1995
Guidelines for testing slow acting drugs in arthritis--addendumM Lequesne, K Brandt, N Bellamy, et al.
The Journal of Rheumatology. Supplement|September 1, 1994
Guidelines for testing slow acting drugs in osteoarthritisM Lequesne, K Brandt, N Bellamy, et al.
Plos One|March 22, 2016
Drivers of Vaginal Drug Delivery System Acceptability from Internet-Based Conjoint AnalysisRachel J Primrose, Toral Zaveri, Alyssa J Bakke, et al.
Foods (Basel, Switzerland)|October 31, 2020
Aroma, Quality, and Consumer Mindsets for Shelf-Stable Rice Thermally Processed by Reciprocal AgitationWilliam R Dixon, Blanca E Morales-Contreras, Manoch Kongchum, et al.
Vaccine|March 2, 2024
Developing a novel screening tool to address pediatric COVID-19 vaccine hesitancy at point of careSarah G Yashar-Gershman, Alix T Rosenberg, Muskaan Sawhney, et al.
Journal of Surgical Oncology|January 1, 1991
Adjuvant, specific, active immunotherapy for resectable squamous cell lung carcinoma: a 5-year survival analysisH Takita, A C Hollinshead, R H Adler, et al.
Osteoarthritis and Cartilage|July 22, 2006
Commentary: osteoarthritis of the knee and glucosamineR D Altman, S Abramson, O Bruyere, et al.
Journal of Cardiovascular Pharmacology|June 8, 2001
Dose-dependent blockade of the angiotensin II type 1 receptor with losartan in normal volunteersM S Berlowitz, F Latif, S R Hankins, et al.
Annals of the Rheumatic Diseases|April 15, 2004
Patient Preference for Placebo, Acetaminophen (paracetamol) or Celecoxib Efficacy Studies (PACES): two randomised, double blind, placebo controlled, crossover clinical trials in patients with knee or hip osteoarthritisT Pincus, G Koch, H Lei, et al.
Pageof 7